GB8929097D0 - Mucin nucleotides - Google Patents

Mucin nucleotides

Info

Publication number
GB8929097D0
GB8929097D0 GB898929097A GB8929097A GB8929097D0 GB 8929097 D0 GB8929097 D0 GB 8929097D0 GB 898929097 A GB898929097 A GB 898929097A GB 8929097 A GB8929097 A GB 8929097A GB 8929097 D0 GB8929097 D0 GB 8929097D0
Authority
GB
United Kingdom
Prior art keywords
mucin
nucleotides
mucin nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898929097A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Horizons Ltd
Original Assignee
Imperial Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Cancer Research Technology Ltd filed Critical Imperial Cancer Research Technology Ltd
Priority to GB898929097A priority Critical patent/GB8929097D0/en
Publication of GB8929097D0 publication Critical patent/GB8929097D0/en
Priority to EP91901847A priority patent/EP0506815A1/en
Priority to PCT/GB1990/002020 priority patent/WO1991009867A1/en
Priority to JP3502108A priority patent/JPH05502789A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB898929097A 1989-12-22 1989-12-22 Mucin nucleotides Pending GB8929097D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB898929097A GB8929097D0 (en) 1989-12-22 1989-12-22 Mucin nucleotides
EP91901847A EP0506815A1 (en) 1989-12-22 1990-12-24 Mucin nucleotides
PCT/GB1990/002020 WO1991009867A1 (en) 1989-12-22 1990-12-24 Mucin nucleotides
JP3502108A JPH05502789A (en) 1989-12-22 1990-12-24 mucin nucleotide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898929097A GB8929097D0 (en) 1989-12-22 1989-12-22 Mucin nucleotides

Publications (1)

Publication Number Publication Date
GB8929097D0 true GB8929097D0 (en) 1990-02-28

Family

ID=10668442

Family Applications (1)

Application Number Title Priority Date Filing Date
GB898929097A Pending GB8929097D0 (en) 1989-12-22 1989-12-22 Mucin nucleotides

Country Status (4)

Country Link
EP (1) EP0506815A1 (en)
JP (1) JPH05502789A (en)
GB (1) GB8929097D0 (en)
WO (1) WO1991009867A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054438A (en) * 1987-01-07 2000-04-25 Imperial Cancer Research Technology Limited Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin
WO1994016057A1 (en) * 1992-12-31 1994-07-21 Dana-Farber Cancer Institute, Inc. Enhancer sequence for modulating expression in epithelial cells
IL110464A0 (en) * 1994-07-26 1994-10-21 Univ Ramot Novel proteins for the diagnosis, imaging, and therapy of human cancer
US6548643B1 (en) 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
DE19547324C2 (en) * 1995-12-19 1997-10-16 Behringwerke Ag Human Mucin (MUC8)
GB9708190D0 (en) * 1997-04-23 1997-06-11 Univ Leicester Cancer marker
GB9712370D0 (en) 1997-06-14 1997-08-13 Aepact Ltd Therapeutic systems
AU780395B2 (en) * 2000-02-01 2005-03-17 Austin Research Institute, The Mucin-1 derived antigens and their use in immunotherapy
WO2001057068A1 (en) * 2000-02-01 2001-08-09 The Austin Research Institute Mucin-1 derived antigens and their use in immunotherapy
GB0008966D0 (en) 2000-04-13 2000-05-31 Imp College Innovations Ltd Vectors for gene therapy
EP1531842A4 (en) 2000-12-22 2007-03-07 Dana Farber Cancer Inst Inc Regulation of cell growth by muc1
WO2005042573A1 (en) 2003-10-24 2005-05-12 Dana-Farber Cancer Institute, Inc. Modulation of the interaction of muc1 with muc1 ligands
US7871784B2 (en) 2007-02-02 2011-01-18 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins
WO2008097840A2 (en) 2007-02-02 2008-08-14 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of muc1 by hsf1 and stat3

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1103988A (en) * 1987-01-07 1988-07-27 Imperial Cancer Research Technology Limited Probe
EP0442926A1 (en) * 1988-11-10 1991-08-28 Imperial Cancer Research Technology Limited Polypeptides

Also Published As

Publication number Publication date
WO1991009867A1 (en) 1991-07-11
JPH05502789A (en) 1993-05-20
EP0506815A1 (en) 1992-10-07

Similar Documents

Publication Publication Date Title
US5210846B1 (en) One-wire bus architecture
EP0406309A4 (en) Oligonucleotide n-alkylphosphoramidates
GB8719485D0 (en) Shaped articles
ZA89440B (en) Dideoxydidehydrocarbocyclic nucleosides
GB2217320B (en) Dideoxydidehydrocarbocyclic nucleosides
GB8929097D0 (en) Mucin nucleotides
HK41196A (en) Signal-source arrangement
GB9011927D0 (en) Shaped articles
OA09697A (en) Nucleoside derivatives
EP0450102A4 (en) Nucleoside derivative
GB2207864B (en) Antiviral composition comprising isopropyldeoxyuridine
GB9110987D0 (en) Dideoxydidehydrocarboxyclic nucleosides
ZA87641B (en) Acylated sulphonylguanidines
GB8915642D0 (en) Variant nucleotides
GB8920009D0 (en) Variant nucleotides
GB2232009B (en) Spacing member
GB8919861D0 (en) Shelf
GB8916323D0 (en) Nucleosides
IE892332L (en) Nucleosides
IE891036L (en) Fluorophonate nucleotide derivatives
IE891764L (en) Nucleoside compositions
IE870520L (en) Isohexide nucleoside
GB8913677D0 (en) Macrolide
GB8918759D0 (en) Macrolide
GB8918176D0 (en) Nucleotide sequence determination